Rising Endometrial Cancer Incidence: Clinical Priorities in Evaluation and Management - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Rising Endometrial Cancer Incidence: Clinical Priorities in Evaluation and Management

  • By

  • October 21, 2026

  • 6 min

Share

  • 1

    Endometrial cancer incidence is rising in the United States and globally, with population aging and obesity identified as important contributors.

  • 2

    Any postmenopausal bleeding, including spotting, warrants evaluation; new or unexplained bleeding-pattern changes in younger patients also merit assessment.

  • 3

    Initial evaluation may include bleeding history, pelvic examination and transvaginal ultrasound, but diagnosis requires endometrial tissue sampling.

  • 4

    Treatment depends on histology and stage; early-stage disease may be treated with hysterectomy, while advanced disease may require multimodality therapy.

  • 5

    Carefully selected patients with certain early-stage endometrioid cancers may consider fertility-sparing treatment with close surveillance.

Original Source(s)

Related Content